Summary
Hoba Therapeutics, a Novo Holdings-founded Danish biotech company dedicated to developing novel therapeutic proteins for patients living with chronic neuropathic pain and hearing loss
Deals Overview
Senior Management
Torsten M. Madsen
CEO
All rights reserved. Copyright © 2025 Datasite